2 false false false false false false false false false false true false false false false false false No description of principal activity 2023-08-01 Sage Accounts Production Advanced 2023 - FRS102_2023 4,824 1,399 2,037 4,186 4,004 428 1,898 2,534 1,652 820 xbrli:pure xbrli:shares iso4217:GBP 08207501 2023-08-01 2024-07-31 08207501 2024-07-31 08207501 2023-07-31 08207501 2022-10-01 2023-07-31 08207501 2023-07-31 08207501 2022-09-30 08207501 bus:RegisteredOffice 2023-08-01 2024-07-31 08207501 bus:LeadAgentIfApplicable 2023-08-01 2024-07-31 08207501 bus:Director1 2023-08-01 2024-07-31 08207501 core:WithinOneYear 2024-07-31 08207501 core:WithinOneYear 2023-07-31 08207501 core:AfterOneYear 2023-07-31 08207501 core:ShareCapital 2024-07-31 08207501 core:ShareCapital 2023-07-31 08207501 core:RetainedEarningsAccumulatedLosses 2024-07-31 08207501 core:RetainedEarningsAccumulatedLosses 2023-07-31 08207501 core:AcceleratedTaxDepreciationDeferredTax 2024-07-31 08207501 core:AcceleratedTaxDepreciationDeferredTax 2023-07-31 08207501 bus:SmallEntities 2023-08-01 2024-07-31 08207501 bus:AuditExemptWithAccountantsReport 2023-08-01 2024-07-31 08207501 bus:SmallCompaniesRegimeForAccounts 2023-08-01 2024-07-31 08207501 bus:PrivateLimitedCompanyLtd 2023-08-01 2024-07-31 08207501 bus:FullAccounts 2023-08-01 2024-07-31 08207501 core:ComputerEquipment 2023-08-01 2024-07-31 08207501 core:ComputerEquipment 2023-07-31 08207501 core:ComputerEquipment 2024-07-31
COMPANY REGISTRATION NUMBER: 08207501
Implantalex Limited
Filleted Unaudited Financial Statements
For the year ended
31 July 2024
Implantalex Limited
Financial Statements
Year ended 31 July 2024
Contents
Pages
Officers and professional advisers
1
Statement of financial position
2 to 3
Notes to the financial statements
4 to 6
Implantalex Limited
Officers and Professional Advisers
DIRECTOR
A R Presada
REGISTERED OFFICE
4 Hempsals
Eaton Ford
St Neots
Cambridgeshire
PE19 7QZ
ACCOUNTANTS
Streets
Chartered Accountants
Potton House
Wyboston Lakes
Great North Road
Wyboston
Bedford
MK44 3BZ
BANKERS
Barclays Bank Plc
De Montford Street
Leicester
LE87 2BB
Implantalex Limited
Statement of Financial Position
31 July 2024
2024
2023
Note
£
£
£
Fixed assets
Tangible assets
5
1,652
820
Current assets
Debtors
6
35,562
31,535
Cash at bank and in hand
1,634
625
--------
--------
37,196
32,160
Creditors: amounts falling due within one year
7
37,471
26,132
--------
--------
Net current (liabilities)/assets
( 275)
6,028
-------
-------
Total assets less current liabilities
1,377
6,848
Creditors: amounts falling due after more than one year
8
6,944
Provisions
Deferred taxation
413
205
-------
-------
Net assets/(liabilities)
964
( 301)
-------
-------
Capital and reserves
Called up share capital
100
100
Profit and loss account
864
( 401)
----
----
Shareholders funds/(deficit)
964
( 301)
----
----
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.
For the year ending 31 July 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
Implantalex Limited
Statement of Financial Position (continued)
31 July 2024
These financial statements were approved by the board of directors and authorised for issue on 23 November 2024 , and are signed on behalf of the board by:
A R Presada
Director
Company registration number: 08207501
Implantalex Limited
Notes to the Financial Statements
Year ended 31 July 2024
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 4 Hempsals, Eaton Ford, St Neots, Cambridgeshire, PE19 7QZ.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis. The financial statements are prepared in sterling, which is the functional currency of the entity.
Revenue recognition
The turnover shown in the statement of income and retained earnings account represents the value of work carried out during the year and includes accrued income in respect of ongoing contracts.
Taxation
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date. Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the reporting date where transactions or events have occurred at that date that will result in an obligation to pay more, or a right to pay less or to receive more tax. Deferred tax is measured on an undiscounted basis at the tax rates that are expected to apply in the periods in which timing differences reverse, based on tax rates and laws enacted or substantively enacted at the reporting date.
Tangible assets
Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses.
Depreciation
Depreciation is calculated so as to write off the cost, less its residual value, over the useful economic life of that asset as follows:
Equipment
-
33% straight line
4. Employee numbers
The average number of persons employed by the company during the year amounted to 2 (2023: 2 ).
5. Tangible assets
Equipment
£
Cost
At 1 August 2023
4,824
Additions
1,399
Disposals
( 2,037)
-------
At 31 July 2024
4,186
-------
Depreciation
At 1 August 2023
4,004
Charge for the year
428
Disposals
( 1,898)
-------
At 31 July 2024
2,534
-------
Carrying amount
At 31 July 2024
1,652
-------
At 31 July 2023
820
-------
6. Debtors
2024
2023
£
£
Trade debtors
222
Other debtors
35,340
31,535
--------
--------
35,562
31,535
--------
--------
7. Creditors: amounts falling due within one year
2024
2023
£
£
Bank loans and overdrafts
3,057
Social security and other taxes
33,527
18,914
Other creditors
3,944
4,161
--------
--------
37,471
26,132
--------
--------
8. Creditors: amounts falling due after more than one year
2024
2023
£
£
Bank loans and overdrafts
6,944
----
-------
9. Deferred tax
The deferred tax included in the statement of financial position is as follows:
2024
2023
£
£
Included in provisions
413
205
----
----
The deferred tax account consists of the tax effect of timing differences in respect of:
2024
2023
£
£
Accelerated capital allowances
413
205
----
----
10. Director's advances, credits and guarantees
The director maintains a loan account with the company. At the beginning of the year the director owed the company £21,480. During the year there were advances to the director of £155,338 (2023: £108,450) and repayments of £155,492 (2023: £99,537). At the year end date the director owed the company £21,659. During the year interest of £333 (2023: £126) was charged and no amounts were written off.